New Survey Sheds Light on Pill-Splitting in Parkinson’s Disease Treatment A new survey released by Avion Pharmaceuticals, a subsidiary of Alora Pharmaceuticals, highlights a persistent challenge in Parkinson’s disease (PD) management: the need to split pills to manage dosage, timing, and side effects. The findings, drawn from responses of patients, caregivers, and clinicians, underscore how…